SAN RAMON, Calif., September 29 2020—The COVID-19 pandemic is accelerating patient demand for health and safety, quality, and convenience in many areas of life, including contact lens wear. This trend presents an opportunity for eye care professionals to make a shift to silicone hydrogel 1-day contact lenses for the benefit of patients—and practices. CooperVision has launched a new program called “SiHy 1-Day: The Time is Now,” which begins with a series of webinars featuring practitioners who have already made this change in their practices.
“As eye care professionals, we know that the path to success is never linear. Challenges can be turned into opportunities, and if there was ever a time to make a change, it’s now,” said Steve Rosinski, OD, Senior Manager of North America Professional and Academic Affairs, CooperVision. “At CooperVision, we are well-suited to be your partner in elevating the value of SiHy 1-day lenses to your patients due to our leadership in SiHys and broad product portfolio. Through this program, we will leverage the expertise of your peers, who will provide insights into how to have these patient discussions, particularly given the current climate.”
The series of three webinars are scheduled for October and feature Jack McIntyre, OD, of Drs McIntyre, Garza, Avila & Jurica in Corpus Christi, Texas; Drew Provost, OD, of Great Hills Eye Care in Austin, Texas; and Jennifer Stewart, OD, of Norwalk Eye Care in Norwalk, Conn. The three practitioners will engage in live discussion about their experiences and provide helpful ways for their peers to adapt and harness the current trends.
The schedule is as follows:
- SiHy 1-Day: The Time is Now – The Trend Towards Health and Safety
Wednesday, October 14th, 2020, 7:30 – 8:00 pm EDT
- SiHy 1-Day: The Time is Now – Why Quality Matters More Than Ever
Tuesday, October 20th, 2020, 7:30 – 8:00 pm EDT
- SiHy 1-Day: The Time is Now – Simplifying Wearing Experiences
Wednesday, October 28th, 2020, 7:30 – 8:00 pm EDT
In addition to the live sessions, these webinars will be recorded and available for on-demand viewing. CooperVision will also provide access to support tools, including articles, videos, and helpful checklists with steps practices can take to fully integrate silicone hydrogel 1-day contact lenses into their patient care routines.
# # #
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of daily disposable, two-week and monthly contact lenses, all featuring advanced materials and optics. CooperVision has a strong heritage of solving the toughest vision challenges such as astigmatism, presbyopia and childhood myopia; and offers the most complete collection of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Heather Kowalczyk, APR
McDougall Communications for CooperVision, Inc.
email@example.com or +1-585-434-2148